Smith & Nephew plc (SNNUF)
OTCMKTS
· Delayed Price · Currency is USD
15.00
+0.77 (5.37%)
Jun 5, 2025, 9:34 AM EDT
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue
5.81B
Revenue Growth
+4.70%
P/S Ratio
2.29
Revenue / Employee
334.89K
Employees
17,349
Market Cap
13.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Smith & Nephew News
- 10 days ago - Smith+Nephew wins a DoD supply contract worth up to $75M - Seeking Alpha
- 11 days ago - Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense - GlobeNewsWire
- 4 weeks ago - Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹* - GlobeNewsWire
- 4 weeks ago - Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland - GlobeNewsWire
- 5 weeks ago - Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Smith & Nephew: Underappreciated Recovery With Strategic Upside - Seeking Alpha
- 2 months ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 3 months ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire